Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claudine Bekondi is active.

Publication


Featured researches published by Claudine Bekondi.


Journal of Clinical Microbiology | 2002

Chronic Diarrhea, Hemorrhagic Colitis, and Hemolytic-Uremic Syndrome Associated with HEp-2 Adherent Escherichia coli in Adults Infected with Human Immunodeficiency Virus in Bangui, Central African Republic

Christian Mossoro; Philippe Glaziou; Simon Yassibanda; Nguyen Thi Phuong Lan; Claudine Bekondi; Pierre Minssart; Christine Bernier; Chantal Le Bouguénec; Yves Germani

ABSTRACT In human immunodeficiency virus (HIV)-infected adults from the Central African Republic, the occurrence of chronic diarrhea due to HEp-2 adherent Escherichia coli (EAEC) harboring virulence markers (eaeA, BFP, EAF, astA determinant of EAST/1, positive FAS test, enteropathogenic E. coli O serogroup) was shown to be associated with AIDS. We also show that EAEC that produce verotoxin (Stx2) but do not harbor the genetic markers for classical enterohemorrhagic E. coli are involved in hemorrhagic colitis and hemolytic-uremic syndrome in patients with HIV.


Pediatric Infectious Disease Journal | 2013

Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.

Marie-Anne Rey-Cuille; Richard Njouom; Claudine Bekondi; Abdoulaye Seck; Chrysostome Gody; Petulla Bata; Benoit Garin; Sarah Maylin; Loïc Chartier; François Simon; Muriel Vray

Background: More than 2 billion people worldwide have been exposed to hepatitis B virus (HBV). To prevent these infections, Senegal and Cameroon integrated the HBV vaccine into their Expanded Program on Immunization (EPI) in 2005, as did the Central African Republic (CAR) in 2008. We evaluated the prevalence of HBV exposure and infection after the integration of the HBV vaccine in the EPI. Methods: An observational cross-sectional study was conducted among the hospitalized children 3 months to 6 years of age in Cameroon, CAR and Senegal. Plasma was collected for the detection of anti-HBc, anti-HBs and hepatitis B surface antigen in children with anti-HBc and anti-HBs. Results: Between April 2009 and May 2010, 1783 children were enrolled, 19.4% of whom were anti-HBc positive. The percentage of children with anti-HBc was 44.4% among the children younger than 6 months, decreasing after 6 months to reach 18.8% at 12 months. This decline was followed by a rapid increase in anti-HBc positivity rate in CAR observed as early as 12 months of age compared with Cameroon and Senegal, where the anti-HBc increased between 18 and 36 months of age, respectively. The prevalence of hepatitis B surface antigen–positive children was significantly higher in CAR than that in Cameroon and Senegal (5.1% versus 0.7% and 0.2%; P < 0.001). Socioeconomic level, age and country were factors associated with the presence of anti-HBc. Conclusions: Passive transfer of anti-HBc maternal antibodies versus HBV exposure could be differentiated as early as 12 months of age. The low prevalence of anti-HBc and hepatitis B surface antigen among children born after the integration of HBV vaccine in the EPI in Cameroon and Senegal suggests a positive impact of HBV vaccination.


The Pan African medical journal | 2017

Free-living amoebae isolated in the Central African Republic: epidemiological and molecular aspects

Alain Farra; Claudine Bekondi; Vianney Tricou; Jean Robert Mbecko; Antoine Talarmin

Among the many species of free-living amoebae infecting humans, only Naegleria fowleri, a few species of Acanthamoeba, Balamuthia mandrillaris recently Sappinia diploïdea and Paravahlkampfia Francina are responsible for human diseases especially deadly encephalitis outside of Acanthamoeba keratitis related. In the Central African Republic (CAR), no studies have previously been conducted about free amoebae and no suspicious cases of encephalitis or amoebic keratitis was reported even though the ecosystem supported the proliferation of these microorganisms. The objective of this study was to identify free-living amoebae present in CAR and to define the molecular characteristic. Bathing sites and cerebrospinal fluid from patients died of bacterial meningitis untagged were explored by culture and PCR and the amplicons were sequenced which allowed to characterize the species found. Only species of the genus Tetramitus, namely T. Entericus, T. waccamawensis and T.sp similar to those already described in the world and not pathogenic for humans were found in bathing sites, the cerebrospinal fluid meanwhile remained negative. Although no pathogen species such as Naegleria fowleri or species of Acanthamoeba have been isolated, this study worth pursuing because this investigation was very limited in space because of the insecurity in the country.


PLOS Neglected Tropical Diseases | 2018

Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults

Narcisse P Komas; Sumantra Ghosh; Mariama Abdou-Chekaraou; Pierre Pradat; Nasser Al Hawajri; Alexandre Manirakiza; Gina Laure Laghoe; Claudine Bekondi; Ségolène Brichler; Jean-Omer Ouavéné; Abdoulaye Sépou; Brice Martial Yambiyo; Jean Chrysostome Gody; Valentin Fikouma; Athenaïs Gerber; Natali Abeywickrama Samarakoon; Dulce Alfaiate; Caroline Scholtes; Nora Martel; Frédéric Le Gal; Hugo Lo Pinto; Ikram Amri; Olivier Hantz; David Durantel; Jean-Louis Lesbordes; Emmanuel Gordien; Philippe Merle; Tudor Drugan; Christian Trepo; Fabien Zoulim

Hepatitis delta virus (HDV) increases morbidity in Hepatitis B virus (HBV)-infected patients. In the mid-eighties, an outbreak of HDV fulminant hepatitis (FH) in the Central African Republic (CAR) killed 88% of patients hospitalized in Bangui. We evaluated infections with HBV and HDV among students and pregnant women, 25 years after the fulminant hepatitis (FH) outbreak to determine (i) the prevalence of HBV and HDV infection in this population, (ii) the clinical risk factors for HBV and/or HDV infections, and (iii) to characterize and compare the strains from the FH outbreak in the 1980s to the 2010 HBV–HDV strains. We performed a cross sectional study with historical comparison on FH-stored samples (n = 179) from 159 patients and dried blood-spots from volunteer students and pregnant women groups (n = 2172). We analyzed risk factors potentially associated with HBV and HDV. Previous HBV infection (presence of anti-HBc) occurred in 345/1290 students (26.7%) and 186/870 pregnant women (21.4%)(p = 0.005), including 110 students (8.8%) and 71 pregnant women (8.2%), who were also HBsAg-positive (p = 0.824). HDV infection occurred more frequently in pregnant women (n = 13; 18.8%) than students (n = 6; 5.4%) (p = 0.010). Infection in childhood was probably the main HBV risk factor. The risk factors for HDV infection were age (p = 0.040), transfusion (p = 0.039), and a tendency for tattooing (p = 0.055) and absence of condom use (p = 0.049). HBV-E and HDV-1 were highly prevalent during both the FH outbreak and the 2010 screening project. For historical samples, due to storage conditions and despite several attempts, we could only obtain partial HDV amplification representing 25% of the full-length genome. The HDV-1 mid-eighties FH-strains did not form a specific clade and were affiliated to two different HDV-1 African subgenotypes, one of which also includes the 2010 HDV-1 strains. In the Central African Republic, these findings indicate a high prevalence of previous and current HBV-E and HDV-1 infections both in the mid-eighties fulminant hepatitis outbreak and among asymptomatic young adults in 2010, and reinforce the need for universal HBV vaccination and the prevention of HDV transmission among HBsAg-positive patients through blood or sexual routes.


Clinical and Experimental Medicine | 2018

Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma

Agnès Marchio; Marie Amougou Atsama; Aubin Béré; Narcisse-Patrice Komas; Dominique Noah Noah; Paul Jean Adrien Atangana; Serge-Magloire Camengo-Police; Richard Njouom; Claudine Bekondi; Pascal Pineau

Hepatocellular carcinoma (HCC) is still a major killing malignancy in sub-Saharan Africa. Lifelong intoxication with aflatoxin B1 is considered as one of the primary causes of this situation. The role of aflatoxin in HCC from a given population is commonly estimated through the prevalence of R249S mutation of TP53, a hallmark for previous exposure to the mycotoxin. However, the role of AFB1 is barely known in large part of Africa. We conducted a survey on circulating cell-free DNA from 149 patients with HCC and 213 control subjects with and without liver diseases from Cameroon and Central African Republic using droplet digital PCR technique. We observed a mutation prevalence of 24.8% (n = 37/149) in patients with tumor and 5.6% (n = 12/213) in controls (P = 2.2E−07). Patients with mutations usually displayed significantly increased circulating alpha-fetoprotein (AFP) values, high hepatitis B virus (HBV) DNA loads as well as worsened values of blood cells count. Interestingly, the fraction of droplets positive for R249S was significantly larger in patients with liver cancer (15.3 ± 3.7%) than in controls (0.5 ± 0.3%, P = 7.1E−04). Our survey indicates that AFB1 is instrumental for HCC development in Middle Africa and that droplet digital PCR might be used in the region both to diagnose HCC and to conduct public health surveys on populations at risk of chronic aflatoxin intoxication.


International Journal of Infectious Diseases | 2006

Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus

Claudine Bekondi; Claire Bernède; Noella Passone; Pierre Minssart; Come Kamalo; Didier Mbolidi; Yves Germani


Journal of Clinical Virology | 2007

Central African Republic is part of the West-African hepatitis B virus genotype E crescent

Claudine Bekondi; Christophe M. Olinger; Nathalie Boua; Antoine Talarmin; Claude P. Muller; Alain Le Faou; Véronique Venard


BMC Infectious Diseases | 2015

HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study

Claudine Bekondi; Roberta Zanchi; Abdoulaye Seck; Benoit Garin; Tamara Giles-Vernick; Jean Chrysotome Gody; Petulla Bata; Angèle Pondy; Suzie Moyo Tetang; Mamadou Ba; Chantal Same Ekobo; Dominique Rousset; Jean-Marie Sire; Sarah Maylin; Loïc Chartier; Richard Njouom; Muriel Vray


American Journal of Tropical Medicine and Hygiene | 2006

ENTEROPATHOGENIC ESCHERICHIA COLI O157 IN BANGUI AND N’GOILA, CENTRAL AFRICAN REPUBLIC: A BRIEF REPORT

Dinh Thi N. Tuyet; Simon Yassibanda; Phuong L. Nguyen Thi; Marcel R. Koyenede; Malika Gouali; Claudine Bekondi; Jean Mazzi; Yves Germani


Pathologie Biologie | 2010

Étiopathologie du carcinome hépatocellulaire à Bangui, République centrafricaine : caractéristiques cliniques, biologiques et aspects virologiques des patients

Claudine Bekondi; T. Mobima; J.O. Ouavènè; B. Koffi; X. Konamna; Aubin Béré; A. Le Faou

Collaboration


Dive into the Claudine Bekondi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge